|
|
|
|
| LEADER |
01715cam a2200409 4500 |
| 001 |
PPN177482788 |
| 003 |
http://www.sudoc.fr/177482788 |
| 005 |
20140827032300.0 |
| 010 |
|
|
|a 978-2-84950-38-29
|b br.
|d 8 EUR
|
| 021 |
|
|
|a FR
|b DLE-20140225-13917
|
| 035 |
|
|
|a (OCoLC)876118243
|
| 073 |
|
1 |
|a 9782849503829
|
| 100 |
|
|
|a 20140409h20132014m y0frey0103 ba
|
| 101 |
0 |
|
|a fre
|
| 102 |
|
|
|a FR
|
| 105 |
|
|
|a a z 000yd
|
| 106 |
|
|
|a r
|
| 200 |
1 |
|
|a Sanofi
|b Texte imprimé
|e big pharma
|e l'urgence de la maîtrise sociale
|f Danielle Montel, Daniel Vergnaud, Danielle Sanchez, Thierry Nodin
|
| 210 |
|
|
|a Paris
|c Syllepse
|d DL 2013, cop. 2014
|
| 215 |
|
|
|a 1 vol. (142 p.)
|c ill.
|d 19 cm
|
| 225 |
2 |
|
|a Arguments et mouvements
|
| 410 |
|
| |
|0 048114863
|t Arguments-mouvements
|x 1294-6508
|
| 601 |
0 |
2 |
|3 PPN027563022
|a Sanofi
|2 rameau
|
| 606 |
|
|
|3 PPN027243192
|a Politique sanitaire
|3 PPN027226794
|y France
|3 PPN033466300
|z 1990-....
|2 rameau
|
| 606 |
|
|
|3 PPN027292630
|a Industrie pharmaceutique
|3 PPN027226794
|y France
|3 PPN033466300
|z 1990-....
|2 rameau
|
| 606 |
|
|
|3 PPN027292630
|a Industrie pharmaceutique
|3 PPN028644905
|x Aspect économique
|2 rameau
|
| 606 |
|
|
|3 PPN027292630
|a Industrie pharmaceutique
|3 PPN027790088
|x Aspect social
|2 rameau
|
| 606 |
|
|
|3 PPN040696820
|a Industrie pharmaceutique
|3 PPN038961563
|x organisation et administration
|2 fmesh
|
| 700 |
|
1 |
|3 PPN177570679
|a Montel
|b Danielle
|4 070
|
| 701 |
|
1 |
|3 PPN177570709
|a Vergnaud
|b Daniel
|4 070
|
| 701 |
|
1 |
|3 PPN177570768
|a Sanchez
|b Danielle
|4 070
|
| 701 |
|
1 |
|3 PPN177570822
|a Nodin
|b Thierry
|4 070
|
| 801 |
|
3 |
|a FR
|b Electre
|c 20140108
|g AFNOR
|
| 801 |
|
3 |
|a FR
|b Abes
|c 20140606
|g AFNOR
|
| 930 |
|
|
|5 441092102:511684495
|b 441092102
|a 362.06 MON
|j u
|
| 979 |
|
|
|a LET
|
| 998 |
|
|
|a 668177
|
Nantilus
